Vaginal Bromocriptine for Treatment of Adenomyosis

Completed · Phase 1

Conditions studied: Adenomyosis

In brief

Adenomyosis is a rare non-malignant disease of the uterus that causes significant symptoms including heavy menstrual bleeding and pelvic pain. The only widely accepted treatment for adenomyosis is hysterectomy. The investigators will use a dopamine agonist, bromocriptine, as a therapy based on animal models of the disease and our prior clinical research to observe any objective improvement in the extent of the disease using Magnetic Resonance Imaging (MRI)and standard measurements for other gynecologic diseases to measure symptomatology.

Key facts

Study ID
NCT01821001
Run by
Mayo Clinic
People needed
1
Starts
2013-03-01
Expected to finish
2018-01-01
Last updated by the study team
2018-01-12

Who can join

Age: 25 and older, up to 55. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.